KLP Kapitalforvaltning AS Has $18.78 Million Holdings in Axon Enterprise, Inc (NASDAQ:AXON)

KLP Kapitalforvaltning AS grew its position in shares of Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 3.8% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 35,700 shares of the biotechnology company's stock after buying an additional 1,300 shares during the quarter. KLP Kapitalforvaltning AS's holdings in Axon Enterprise were worth $18,776,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also made changes to their positions in the company. Fourth Dimension Wealth LLC acquired a new position in Axon Enterprise during the 4th quarter worth $30,000. Bartlett & CO. Wealth Management LLC lifted its position in shares of Axon Enterprise by 132.0% during the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 58 shares of the biotechnology company's stock worth $31,000 after purchasing an additional 33 shares during the last quarter. Catalyst Capital Advisors LLC acquired a new position in shares of Axon Enterprise during the first quarter worth approximately $32,000. Alpine Bank Wealth Management acquired a new position in shares of Axon Enterprise during the first quarter worth approximately $40,000. Finally, Elequin Capital LP acquired a new position in shares of Axon Enterprise during the fourth quarter worth approximately $46,000. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, Director Caitlin Elizabeth Kalinowski sold 1,300 shares of Axon Enterprise stock in a transaction on Monday, May 19th. The stock was sold at an average price of $738.84, for a total value of $960,492.00. Following the completion of the sale, the director directly owned 4,829 shares of the company's stock, valued at approximately $3,567,858.36. This trade represents a 21.21% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CAO Jennifer H. Mak sold 75 shares of Axon Enterprise stock in a transaction dated Friday, June 13th. The stock was sold at an average price of $771.81, for a total value of $57,885.75. Following the completion of the sale, the chief accounting officer owned 15,240 shares of the company's stock, valued at approximately $11,762,384.40. The trade was a 0.49% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 34,642 shares of company stock valued at $25,090,528 over the last quarter. Company insiders own 4.40% of the company's stock.

Axon Enterprise Price Performance

Shares of NASDAQ:AXON traded up $25.75 during midday trading on Friday, reaching $735.01. The company's stock had a trading volume of 654,601 shares, compared to its average volume of 627,317. Axon Enterprise, Inc has a fifty-two week low of $279.02 and a fifty-two week high of $830.21. The company has a market capitalization of $57.22 billion, a P/E ratio of 177.54, a P/E/G ratio of 79.06 and a beta of 1.29. The company has a debt-to-equity ratio of 0.68, a current ratio of 2.83 and a quick ratio of 2.62. The business's fifty day simple moving average is $763.82 and its 200-day simple moving average is $650.42.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last posted its quarterly earnings data on Wednesday, May 7th. The biotechnology company reported $1.41 earnings per share for the quarter, beating the consensus estimate of $1.34 by $0.07. The firm had revenue of $603.63 million during the quarter, compared to analysts' expectations of $585.67 million. Axon Enterprise had a net margin of 14.86% and a return on equity of 5.81%. The company's quarterly revenue was up 31.3% compared to the same quarter last year. During the same quarter last year, the company posted $1.15 EPS. As a group, equities research analysts expect that Axon Enterprise, Inc will post 5.8 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities analysts recently commented on AXON shares. Wolfe Research started coverage on shares of Axon Enterprise in a research note on Monday, July 7th. They set an "outperform" rating for the company. UBS Group initiated coverage on shares of Axon Enterprise in a research report on Wednesday, July 16th. They set a "neutral" rating and a $820.00 price objective for the company. Barclays upped their price target on Axon Enterprise from $726.00 to $735.00 and gave the company an "overweight" rating in a report on Friday, May 9th. Bank of America upped their price target on Axon Enterprise from $750.00 to $895.00 and gave the company a "buy" rating in a report on Wednesday, June 4th. Finally, Needham & Company LLC upped their target price on Axon Enterprise from $600.00 to $750.00 and gave the company a "buy" rating in a research note on Thursday, May 8th. One research analyst has rated the stock with a sell rating, two have given a hold rating and eleven have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average price target of $772.08.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.